Recent studies have shown that by targeting a range of crucial regulators and their relevant pathways, SIRT-3 may perform the role of either a tumor suppressor or oncogene by affecting cell growth, leading to a decrease in cell proliferation. The gene discussed is SIRT3; the disease is neoplasm.